ECMO in ARDS – The EOLIA Trial*
Medical information
The EOLIA trial compared the immediate application of ECMO versus continued conventional management (with the potential for cross-over to ECMO) in patients with severe ARDS. Find out more about this topic in our summary.
*Original: Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome. Combes et al. (2018) N Engl J Med 378(21):1965–1975
Disclaimer:
This summary is intended to provide pertinent data to assist healthcare professionals in forming their own conclusions and making decisions. It is not intended to replace the judgment or experience of the attending physician or other medical professionals.
Published treatment recommendations and best practice guidelines discussed in this course may include off-label use of drugs or medical devices. Any such use of drugs or devices should not be considered an endorsement of any indication, dosage or other claim that is not covered, if applicable, in the label approved by your regulatory authority.
The treatment prescription is the sole responsibility of the attending physician.